Scientists Reveal a New Drug That Directs Stem Cells To Desired Sites – Science Times

Researchers at Stanford Burnham Prebys Medical Discovery Institute recently developed a drug that can lure stem cells to impaired tissue and enhance the efficacy of treatment.

This is considered a "scientific first," not to mention a major advance for the field of regenerative drugs. Such a discovery, which theProceedings of the National Academy of Sciences or PNASpublished could enhance the present stem cell treatments developed to cure such neurological disorders like stroke, spinal cord injury, ALS or other amyotrophic lateral sclerosis, as well as other neurodegenerative diseases -- and have their use expanded to new conditions such as arthritis or heart disease.

In the study, toxic or green cells disappeared when mice with a neurodegenerative condition were given both therapeutic or red cells and the drug SDV1a, which matched with delayed onset of symptoms and longer lives.

(Photo : Stem Cell Research via Getty Images)In this undated handout photo released by the Institute for Stem Cell Research in 2005, neurons (red) and astrocytes (green), which can be made from neural stem cells, are seen.

Results Suggesting Efficacy of the Drug

The study results proposed that SDV1a can be used to enhance the stem cell treatments' efficacy. According to Evan Snyder, MD, PhD, theCenter for Stem Cells & Regenerative Medicine at Stanford Burnham Prebysprofessor and director, "the ability to instruct a stem cell where to go in the body, or to a particular region of a given organ is the 'Holy Grail' for regenerative medicine.

Snyder, who's also the senior author of the study, added, now, for the first time, stem cells can be directed to a desired area and focus its therapeutic effect.

Almost a decade-and-a-half back, the senior author, together with his team, found that stem cells are drawn to infection, a biological 'fire alarm' indicating that damage has taken place.

Nevertheless, using inflammation as a healing appeal is not possible since an inflammation environment can be dangerous to the body. Hence, researchers have been searching for mechanisms to help in the migration of stem cells or 'home' to the body's desired areas.

Such a mechanism or tool, according to reports on this new finding, would be a great contributor for disorders in which preliminary inflammatory indicators disappear over time, like chronic spinal cord injury or stroke, and conditions where the inflammation's role is not clearly understood, like heart disease, for one.

Fortunately, after decades of investing in stem cell science, scientists are now making "tremendous progress," saidCalifornia Institute for Regenerative Medicine or CIRMpresident and CEO Maria Millan, MD said, in their understanding of the manner such cells work and the manner they can be attached to help reverse disease or an injury.

The CIRM partially funded this new study. Millan also said, Snyder's group has identified a medicine that could enhance "the ability of neural stem cells to home to sites of injury and initiate repair."

More so, the president and CEO also explained, the drug candidate could help fast-track the stem cell treatments' development, specifically for conditions including Alzheimer's disease and spinal cord injury.

In the research, study investigators modified an inflammatory molecule called CXCL12, which the Snyder's group discovered previously, could guide healing stem cells to areas that need repair to develop the SDV1a.

As such, this new medicine works by improving stem cell binding and minimizing inflammatory indicating and can be injected anywhere to attract stem cells to a particular site without causing any inflammation.

Since such inflammation can be dangerous, Snyder explained, they modified CXL12 by "tripping away the risky beat and maximizing the good bit."

Now, he added, they have a drug, drawing stem cells to an area of pathology, but not creating or worsening the unwanted infection.

"Now, we have a drug that draws stem cells to a region of pathology, but without creating or worsening unwanted inflammation."

Furthermore, to present that the new medication can improve the effectiveness of stem cell therapy, the scientists implanted SDV1a and human neural stem cells into the brains of mice thatSandhoff disease, a neurodegenerative disease.

The scientists have already started testing the ability of SDV1a to enhance stem cell therapy in a mouse model of Lou Gehrig's disease, also known as ALS, which results from progressive loss of motor neurons in the brain.

Snyder said they are optimistic that the mechanism of action of this new drug may potentially benefit various neurodegenerative disorders and non-neurological conditions like arthritis, heart disease, and even brain cancer.

Interestingly, he also explained, since CXL12 and its receptor is said to be implicated in cytokine storm that exemplifies severeCOVID-19, some of their understandings of how to constrain infection without controlling other normal procedures selectively may be helpful in that field, as well.

RELATED:'Marie Kondo' Protein in Fruit Fly Embryos Helps Them Keep Organized

Check out more news and information onStem Cellsin Science Times.

Read more from the original source:

Scientists Reveal a New Drug That Directs Stem Cells To Desired Sites - Science Times

Stem Cell Therapy Market To Observe Exponential Growth By 2020-2027 | Reports Globe – Cheshire Media

Fort Collins, Colorado The Stem Cell Therapy Market 2020 Research Report provides information on the market size, share, trends, growth, competitive landscape, challenges and opportunities, revenue, and forecast to 2027. Reports Globe recently incorporated a comprehensive overview of the Stem Cell Therapy market into its extensive database. The Stem Cell Therapy Market report has been aggregated by collecting informative data on various dynamics such as market drivers, restraints, and opportunities.

This innovative report uses SWOT, PESTLE, and Porters Five Forces analysis to get a deeper look at the Stem Cell Therapy market.

Global Stem Cell TherapyMarketwas valued at 117.66 million in 2019 and is projected to reach USD255.37 million by 2027, growing at a CAGR of 10.97% from 2020 to 2027.

Impact of Covid-19 on this Market:

The coronavirus pandemic (COVID-19) has affected all aspects of life around the world. The study provides a comprehensive overview of the impact of the COVID-19 pandemic on the Stem Cell Therapy market and its key segments. It also covers the current and future impact of the pandemic and offers a post-COVID-19 scenario to provide a deeper understanding of the dynamic changes in market trends and scenarios.

Competitive Landscape:

Competitive Analysis is one of the best sections of the report, comparing the progress of leading companies using key metrics like market share, new developments, global reach, local competition, pricing, and production. . From the nature of the competition to future changes in the vendor landscape, the report offers an in-depth competitive analysis in the global Stem Cell Therapy Market.

Request a Discount on the report @ https://reportsglobe.com/ask-for-discount/?rid=33553

Market Segments and Sub-segments Covered in the Report are as per below:

1.Stem Cell Therapy Market, By Cell Source:

Adipose Tissue-Derived Mesenchymal Stem Cells Bone Marrow-Derived Mesenchymal Stem Cells Cord Blood/Embryonic Stem Cells Other Cell Sources

2.Stem Cell Therapy Market, By Therapeutic Application:

Musculoskeletal Disorders Wounds and Injuries Cardiovascular Diseases Surgeries Gastrointestinal Diseases Other Applications

3.Stem Cell Therapy Market, By Type:

Allogeneic Stem Cell Therapy Market, By Application Musculoskeletal Disorders Wounds and Injuries Surgeries Acute Graft-Versus-Host Disease (AGVHD) Other Applications Autologous Stem Cell Therapy Market, By Application Cardiovascular Diseases Wounds and Injuries Gastrointestinal Diseases Other Applications

Research Methodology:

Reports Globe follows a comprehensive research methodology to provide the most accurate market analysis. The company relies on a data triangulation model that can be used to assess market dynamics and provide accurate estimates. Key elements of the research methodology used for all of our market reports include:

Request customization of the report @https://reportsglobe.com/need-customization/?rid=33553

In addition, Reports Globe has access to a wide range of reputable regional and global paid databases that help the company understand regional and global market trends and dynamics. The company analyzes the industry from a 360-degree perspective, i.e. H. From the supply and demand side, which allows us to provide detailed information about the entire ecosystem for each study. Finally, a top-down and bottom-up approach is taken to get the final search results.

It includes analysis on the following

Finally, the Stem Cell Therapy Market Report is a credible source of market research that will accelerate your business exponentially. The report gives the most important regional framework conditions, economic situations with item value, advantage, limit, production, supply, demand, market development rate and number, etc. Stem Cell Therapy Industry Report Also includes a new SWOT review task, speculative test research, and corporate return on investment research.

To learn more about the report, visit @ https://reportsglobe.com/product/global-stem-cell-therapy-market/

Thanks for reading this article; you can also get individual chapter wise section or region wise report versions like North America, Europe, or Asia.

How Reports Globe is different than other Market Research Providers

The inception of Reports Globe has been backed by providing clients with a holistic view of market conditions and future possibilities/opportunities to reap maximum profits out of their businesses and assist in decision making. Our team of in-house analysts and consultants works tirelessly to understand your needs and suggest the best possible solutions to fulfill your research requirements.

Our team at Reports Globe follows a rigorous process of data validation, which allows us to publish reports from publishers with minimum or no deviations. Reports Globe collects, segregates, and publishes more than 500 reports annually that cater to products and services across numerous domains.

Contact us:

Mr. Mark Willams

Account Manager

US: +1-970-672-0390

Email:[emailprotected]

Web:reportsglobe.com

View post:

Stem Cell Therapy Market To Observe Exponential Growth By 2020-2027 | Reports Globe - Cheshire Media

Ash 2020 cell therapy preview the battle for recognition – Vantage

The Ash conference is usually a mecca for cell therapy followers. Its 2020 instalment features plenty of Car-T and Car-NK presentations, though investors might rue the fact that these risk being overshadowed by antibody modalities.

Clinical data to watch on adoptive cell therapies include those on Fates allogeneic Car-NK project FT596 and Celyads Cyad-02, a Car using short hairpin RNA technology. Meanwhile, Allovir will want to justify enthusiasm for its recent flotation, whileBCMA-targeted multiple myeloma assets fight to stand out from the crowd.

The most advanced anti-BCMA Car-T therapy is Bristol Myers Squibb/Bluebirds ide-cel, which faces a March 27, 2021 US FDA action date despite an earlier refuse-to-file letter. The asset to watch, however, is Johnson & Johnson/Legend Biotechs cilta-cel, whose Cartitude-1 study is showing a remarkable 95% remission rate, according to the Ash abstract.

Not only that, but Bristol/Bluebirds follow-up, bb21217, looks disappointing, Ash data suggest. A US NCI group including Dr James Kochenderfer, who has also worked on ide-cel, is separately presenting clinical results on a new approach, FHVH-BCMA-T, which uses a heavy chain antibody fragment rather than the normal scFv.

With most abstracts citing relatively early data cut-offs, updates at Ash itself will be keenly awaited. Among these Poseida will no doubt field questions if responses to P-BCMA-101 continue to lookbetter at low than at high doses.

Long time coming

First clinical data on FT596, Fates first Car-modified NK cell approach, have been a long time coming: the FDA signed off the IND in September 2019, but the trial did not start until April this year.

Even so there might be disappointment as the Ash abstract details only a single case study, in a lymphoma subject who went into partial response after a single dose. Expectations for FT596 are high given the 73% response rate cited for an unrelated anti-CD19 Car-NK project run by MD Andersons Dr Katy Rezvani.

There might be more on FT596 at Ash, but some analysts are reining in expectations of meaningful data before next year. In the unmodified NK cell sphere, meanwhile, FC21-NK data could support Sanofis decision to buy Kiadis for $358m this month.

Celyad has been working on Car-T cells targeting NKG2D ligands for some time, but Ash will feature the first clinical data on Cyad-02, a construct that aims to improve on an earlier iteration, Cyad-01.

One problem with Cyad-01 is Car-T fratricide, caused by T cells' own transient expression ofNKG2D ligands; Cyad-02 aims to silence these ligands using shRNA technology. The Ash abstract says Cyad-02 showed threefold better expansion than Cyad-01, and promises to deliver preliminary clinical activity data.

While Cyad-02 is an autologous therapy, Celyad is separately developing allogeneic Cars. One of its allogeneic approaches also usesshRNA for gene silencing, so the Cyad-02 data could provide proof of concept beyond the use in the abstract.

Allogeneic therapies will of course be aired extensively at Ash, and a presidential symposium on 8 December will see UCLAs Dr Gay Crooks discussing universal cell sources. Dr Crookss pluripotent stem cell generation technology was licensed to Kite before that company was bought by Gilead.

Other presentations of general interest include a paper suggesting that CD5 knock-out enhances Car-T cell activity, and another claiming that aberrations in CD58 curtail the efficacy of Yescarta. The latter is also being highlighted at a December 5 press briefing, along with preclinical data on Allovirs anti-Covid-19 T-cell therapy ALVR109.

Investors in Allovir, whose stock has doubled since the group raised $318m in a July IPO, will pay close attention.

Ash 2020 will take place in virtual format on December 5-8.

Vantage analysis previously summarised upcoming Ash presentations that resulted in early share price moves, cancer-focused abstracts outside cell therapy, and those in non-oncology indications.

View original post here:

Ash 2020 cell therapy preview the battle for recognition - Vantage

Animal Stem Cell Therapy Market 2020 to Flourish with an Impressive CAGR of XX% in the year 2026, Market Size & Growth with Complete Business…

Animal Stem Cell Therapy Market report would come handy to understand the competitors in the market and give an insight into sales, volumes, revenues in the Animal Stem Cell Therapy Industry & will also assists in making strategic decisions. The report also helps to decide corporate product & marketing strategies. It reduces the risks involved in making decisions as well as strategies for companies and individuals interested in the Animal Stem Cell Therapy industry. Both established and new players in Animal Stem Cell Therapy industries can use the report to understand the Animal Stem Cell Therapy market.

In Global Market, the Following Companies Are Covered:

Get a Sample Copy of the Report @ https://www.360marketupdates.com/enquiry/request-sample/14828170

Analysis of the Market:

Animal stem cell therapy is a usage of animals stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing the sample to concentrate the stem cells. Finally, the therapy includes transferring the stem cells into the injured site for treatment. Animal stem cell therapy increases the expectancy of life in animals with no side effects. It is available for the treatment of arthritis, degenerative joint disorders, tendon, and ligaments injuries in animals. Stem cell therapy is most often used to treat dogs, cats, and horses. But recent developments made it possible to use animal stem cell therapy in tiger, pig, etc. Present animal stem cell therapy is studied in treatments of the inflammatory bowel, kidney, liver, heart and immune-mediated diseases respectively.

The classification of animal stem cell therapy includes dogs, horses and others. And the proportion of dogs in 2017 is about 50.42%, and the proportion is in increasing trend from 2013 to 2017.

The global Animal Stem Cell Therapy market is valued at 31 million USD in 2020 is expected to reach 291.6 million USD by the end of 2026, growing at a CAGR of 37.3% during 2021-2026.

This report focuses on Animal Stem Cell Therapy volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Animal Stem Cell Therapy market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan et

Animal Stem Cell Therapy Market Breakdown by Types:

Animal Stem Cell Therapy Market Breakdown by Application:

Critical highlights covered in the Global Animal Stem Cell Therapy market include:

The information available in the Animal Stem Cell Therapy Market report is segmented for proper understanding. The Table of contents contains Market outline, Market characteristics, Market segmentation analysis, Market sizing, customer landscape & Regional landscape. For further improving the understand ability various exhibits (Tabular Data & Pie Charts) has also been used in the Animal Stem Cell Therapy Market report.

Get a Sample Copy of the Report @ https://www.360marketupdates.com/enquiry/request-sample/14828170

Reasons for Buy Animal Stem Cell Therapy Market Report:

In the end, Animal Stem Cell Therapy Industry report provides the main region, market conditions with the product price,profit, capacity, production, supply, demand and market growth rateand forecast etc. This report also Present newproject SWOT analysis,investment feasibility analysis, andinvestment return analysis.

Contact Us:

Name: Mr. Ajay More

Email: [emailprotected]

Organization: 360 Market Updates

Phone: +14242530807 / + 44 20 3239 8187

Global Nanosilver Paste Market Size 2020 define, describe, and technology, application, end user, region, commercial study Future Growth by 2026

Global Lug Caps Market Size 2020 Competitive benchmarking, Historical data, Company revenue shares, Regional opportunities, Latest trends & dynamics Future Growth by 2026

Global Coagulation Factors Market report is segmented into several key countries, with market size, growth rate, import and export in these countries from 2020 to 2026

Commercial Aircraft Tire Pressure Monitoring System Market Outlook 2024: Top Companies, consumption by Regional data, Investigation and growth Trends and Growth Factors Details for Business Development

Global Plastic Injection Molding Machine Auxiliary Equipment Market 2020 Analysis, Investigation Growth by Top Companies, consumption by Regional data, Trends by Types and Application, Forecast Analysis to 2026

Water Based Acrylates Copolymer Rheology Modifiers Market 2020 Analysis and In-Depth Research on Market Dynamics, consumption by Regional data, Trends, Investigation and Growth, Emerging Growth Factors and Forecasts To 2024

Global Metal-organic Frameworks Market Size 2020 drivers, opportunities, restraints, challenges, define and technology, application, end user, region, commercial study Future Growth by 2026

Global High-end Inertial Systems Market 2020 Top Companies report covers, Industry Outlook | In-depth Analysis Business Opportunities and Showing Impressive Growth by 2024

Global Traffic Signal Recognition Market 2020 is predicted to rise with a CAGR of by 2026 | According to Top Investors, Covering Sentimental Industry Analysis, Market Size & Growth

See the original post here:

Animal Stem Cell Therapy Market 2020 to Flourish with an Impressive CAGR of XX% in the year 2026, Market Size & Growth with Complete Business...

Semiconductor Leaders Bank on the Power of WBGs – News – All About Circuits

The invention of the silicon integrated circuit (IC) almost 60 years ago paved the way for modern computing and todays tech-fueled electronics era. While silicon isn't going anywhere, in the past few years, alternative semiconductor materials have taken the stage as strong competitorsespecially in the automotive and space industries.

This is occurring withMoores law as the backdrop,the axiom of Gordon Moore, co-founder of Intel, that the number of transistors in an IC doubles roughly every two years.

Its not a situation thats sustainable because as more transistors are packed into a smaller space, more heat is generated. And as time goes by, were very quickly approaching silicons physical limit as design engineers struggle to meet market demands for new devices with greater power density and energy efficiency.

While we dont know for sure when well reach this limitforecasters, including Moore himself, expect it to happen by around 2025what we do know is that we need semiconductor alternatives that can handle theconstraints of miniaturization better than silicon.

Thats where semiconductors like silicon carbide (SiC) and gallium nitride (GaN), wide bandgap (WBG) semiconductors, come in.

WBG semiconductors have drummed up a lot of excitement throughout the semiconductor industry, especially where power electronics are concerned.

The primary benefit of WBGs is that their bandgapsthe energy difference between insulating and conducting statesare much greater than that of silicon. As a result, devices using WBGs can handle higher voltages, operate at higher temperatures, and achieve higher frequencies while using less energy.

However, its a fairly new technology, and devices using WBG semiconductors currently cost more than their silicon-based cousins, which benefit from a proven track record.

To encourage the use of WBG semiconductor technology, the IEEE Power Electronics Society (PELS) released their WBG power semiconductors roadmap in September 2019, a strategic look at the long-term landscape of WBG, its future, and what the possibilities arewell worth a read for those seeking more contextual information about WBG technology.

This year has seen a lot of activity from big semiconductor industry leaders moving to explore technologies like SiC and GaN that offer them more power.

In March, STMicroelectronicswhich has already established a strong presence in the SiC market having first began working on WBG materials in 1996 with SiC MOSFETs and diodesacquired a majority stake in Exagan, a French GaN innovator.

While SiC and GaN are both WBG semiconductors, they address different parts of the power IC market. Thus, the acquisition will allow ST to meet different customer demands across industrial markets.

ST says that its GaN products will address a variety of applications such as power factor correction, DC/DC converters, and adaptors in segments like space, industry, and telecoms. Future developments of ST GaN products will target the automotive sector with on-board chargers for electric vehicles and mild-hybrid DC-DC converters.

More recently, Creeand Infineon were involved in deals that focus on expanding SiC development efforts.

In mid-October, Cree announced the $300 million sale of its LED business to SMART Global Holdings, Inc., a transaction that represents a milestone in Crees transformation to a pure-play global semiconductor powerhouse that will focus on SiC and GaN devices. Crees product line-up already includes SiC, mainly in its Wolfspeedproduct family, but the company is attempting to hone in exclusively on SiC by selling off other elements of the business.

Crees CEO, Gregg Lowe, said that the sale will position the company with a strategic focus capable of leading the transition from Si to SiC and the capital to support continued investments in growth opportunities across electric vehicle, 5G, and industrial applications.

Then in November, Infineon signed a supply agreement with GT Advanced Technologies (GTAT) for SiC boules in response to steadily increasing demand for SiC-based switches for both industrial and automotive applications.

With the supply agreement we have now concluded, we ensure that we will be able to meet the rapidly growing demand of our customers with a diversified supplier base. GTATs high-quality boules will provide an additional source for competitive SiC wafers fulfilling the best-in-class material standards now and in the future, said Peter Wawer, President of Infineons Industrial Power Control Division.

It's activities like these from semiconductor firms that paints a clear picture: WBG semiconductors like SiC and GaN will play a pivotal role as Si-based ICs begin to reach their physical limits and lose their momentum. No doubt, then, well soon begin to see much more of a focus on WBG technologies from semi companies both big and small.

Continue reading here:

Semiconductor Leaders Bank on the Power of WBGs - News - All About Circuits

‘This Election Is a Joke,’ Insists Libertarian-Leaning Congressman Andy Biggs – Reason

There's a parlor trick that libertarians who interact with Capitol Hill sometimes play among themselves, and it usually goes something like this:

Besides the usual suspectsusually understood to be Reps. Justin Amash (LMich.) and Thomas Massie (RKy.) and Sens. Rand Paul (RKy.) and Mike Lee (RUtah)are there any good ones left?

"Let me give you a name of somebody who's come to Congress and really surprised us," Massie told me two years ago. "Andy Biggs from Arizona. If you see two No's on a bill; it's 428 to 2, the two No's will be most often me and Justin Amash. If you see three, it's now Andy Biggs. He's doing it on a constitutional basis. He recognizes when the Republicans are voting for bigger government, and he doesn't fall for it."

Biggs, chair of the House Freedom Caucus, has a 100 percent rating from the limited-government outfit FreedomWorks. He's a reliable vote against federal spending increases, against warrantless surveillance, and in favor of bringing U.S. troops home from Iraq and Afghanistan. He recently became the first GOP member of Congress to support declaring a formal end to the Korean War.

So how is Biggs taking President-elect Joe Biden's victory? By calling Republicans who acknowledge it "Neville Chamberlain's" (sic) who keep "feeding the totalitarian monster, hoping to be eaten last." Such florid language was not an outlier. Here's the top of Biggs's post-election piece for Townhall:

The fierce beast of the Left, the omnivorous viper of the Democrats, has been let loose. Every tyrant needs quislings. Unfortunately, there are appeasers even among Republicans. The 'useful idiots' of the Left are being eaten already; the appeasers will be next.

Those who demand grace from Trump supporters as we watch the nation stolen from us, deny the peril from a ravenous beast that will consume our freedoms and chain the American people.

The passage of days, and the repeated disintegration of the president's conspiracy theories upon contact with the legal system, did nothing to dull Biggs's Trumpian fervor. "This election is a joke," he declared in a video with Rep. Paul Gosar (RAriz.). Watch:

"FACT CHECK: Reps. Andy Biggs, Paul Gosar still touting baseless election-fraud claims," went the Arizona Republic headline (and please do click on the links therein before pre-emptively waving that conclusion away).

In a Washington Times piece Monday, Biggs made the improbable assertion that, "The foundation for the future that Mr.Trumplaid appears to be so strong that the only way to defeat it is to lay waste to any vestige of Americanism and our institutions. And that includes resorting to cheating to try and disenfranchise more than 70 million voters."

Hyperbolic overselling of my-team Potency and their-team Evil is of course not uncommon in politics, even if it's a bit amusing coming from someone fond of using "Derangement Syndrome" as an insult. But Biggs's post-election performance can be read as a cautionary tale about the limits of what might be called "Libertarian Populism" within a Trumpified GOP.

Faced with a crude, big-government nationalist, some office-holding libertarian-leaners of a more temperate dispositionnamely, Amash and former Sen. Jeff Flakechose exit rather than continuing to lose arguments within and face voter hostility from without. Those who remainedMassie, Paul, Biggstend to derive visceral enjoyment from slinging the political bull and coloring outside the lines.

Paul and Massie are considerably more likely to ape Trump's language and selectively amplify his complaints about the Deep State, Fake News Media, and Swamp. And the House Freedom Caucusco-founded by Amash!has long since abandoned its original purpose as a check on executive power in favor of running Trump-protection, even to the distraction of holding the line on spending.

To the extent that there will be any libertarian values in a post-Trump GOP, they will be transmitted via Twitter-firehose from populists like Biggs: anti-war and anti-mask ("Seeing Fauci & Birx at the White House podium yet again brings back months of memories of their work to destroy American freedom and our society as we knew it," he tweeted this week), pro-border wall and pro-Section 230-rewrite.

The congressman's career arc in the age of Trump has drawn some negative reviews. "The descent of U.S. Rep. Andy Biggs into becoming just another partisan brawler has been painful, and disappointing, to watch," concluded Arizona Republic columnist Robert Robb. "Biggs has the talent, and had the opportunity, to be more than that." More from Robb:

As president of the Arizona Senate, Biggs was themost influential state legislator since Burton Barr, the House majority leader for two decades, from 1966 to 1986.

In Congress, he became apublic thought leader for conservatives.His commentary was forceful and sometimes biting. But it had some intellectual depth and focused mostly on substantive policy issues. It was generally more ideological than partisan, serving as much to influence the Republican position as to skewer the Democrats.

But: "With the defeat of Trump in the presidential election, Biggs has gone around the bend."

Biggs, obviously, has a different interpretation: that Trumpism is just getting started, bay-bee. From his Washington Times column:

While the left-wing media apparatus is giddy because to them the election looks like a smackdown of Mr.Trump, they are missing the fact that the president has remodeled the Republican Party and built an infrastructure that can be quite enduring. In fact, it is ironic that the Trump Party is emerging as the most potent force in American politics. It overcame seemingly endless amounts of money for its opponents, a cacophony of hateful media coverage and censorship of its message, and ultimately, what appears to be systemic cheating.

I wish Biggs all the success in the world in persuading the GOP to be more anti-war, anti-surveillance, and anti-spending. And I hope those values are not discredited by their association with partisan conspiracy-mongering.

See more here:

'This Election Is a Joke,' Insists Libertarian-Leaning Congressman Andy Biggs - Reason

Letter to the editor: Biden win is a threat to our liberties – TribLIVE

Our commenting has been temporarily disabled.

You are solely responsible for your comments and by using TribLive.com you agree to ourTerms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sentvia e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.

Read the original:

Letter to the editor: Biden win is a threat to our liberties - TribLIVE

A record 3 million Hoosiers voted in the 2020 election – IndyStar

Indiana voters supported Republican President Donald Trump in the 2020 presidential election with nearly 59% of the ballots with three-quarters of the vote counted. Here's how the state has voted in the past. Wochit

A record 3 million Hoosiers cast their ballots in the Nov. 3 election, according to turnout data released Tuesday by the Indiana secretary of state's office.

Sixty-five percent of the state's 4.7 million voters wanted a say in the top-of-the-ticket race between President Donald Trump and former Vice President Joe Biden, higher than any presidential election since Bill Clinton unseated President George H.W. Bush in 1992. That year 74% of registered Hoosiers voted.

Although Biden won the presidential election nationwide with 306 electoral votes, Trump carried Indiana 57% to 41%.

We continue to see that candidates and issues drive turnout,Secretary of State Connie Lawson said in a prepared statement. Presidential elections tend to have higher turnout rates."

Here are the number of Hoosiers who voted in the past five presidentialelections:

Hamilton County and Wells County had the highest turnout at 75%.Greene, Hancock and Whitley counties followed at 74 percent.

A Congressional race played a pivotal role in the high turnout in Hamilton County.Republican Victoria Spartz defeated Democrat Christina Hale for an open seat that drew national attention and millions of dollars in spending.

Elsewhere in the area, Boone and Hendricks counties were at 72%, Johnson at 70% and Marion at 59%.

An unprecedented 61% of registered Hoosier voters 1.9 million cast their ballots absentee amid the coronavirus pandemic. In the June primary, 51% of registered voters, or552,779 people, voted absentee.

In the last presidential election, 33% voted absentee. In 2012, 22% voted absentee.

Locally, Boone County had 84% vote absentee, Hancock had 82%, Johnson had 79%, Hamilton had 73%, Hendricks had 68% and Marion had 55%.

Gov. Eric Holcomb easily was reelected with 56.5% of the vote. Democratic challenger Woody Myers had 32.1% and Libertarian Donald Rainwater had 11.4%, the highest that party has ever received in a gubernatorial runin Indiana.

Libertarians typically receive3% to 4% in that race.

Rainwater wasn't quite the most successful Libertarian ever to run in Indiana. That record goes toSteve Osborn, who collected 12.6% of the votein the 2006 U.S. Senate race against Richard Lugar when no Democrat ran.

In a more typical three-way race, Andrew Horning has the Indianarecord for a Libertarian candidate inthe 2012 U.S. Senate race. He had 5.6% that year.

Call IndyStar reporter Chris Sikich at 317-444-6036. Follow him on Twitter: @ChrisSikich.

Read or Share this story: https://www.indystar.com/story/news/politics/2020/11/24/indiana-elections-2020-record-3-million-hoosiers-cast-their-vote/6412265002/

More:

A record 3 million Hoosiers voted in the 2020 election - IndyStar

How Trump Pushed Third-Party Voters To Choose Biden In 2020 – KJZZ

STEVE GOLDSTEIN: When Donald Trump defeated Hillary Clinton in the 2016 presidential race, one of the key reasons may have simply been the impact of third-party candidates like Jill Stein of the Green Party and Gary Johnson of the Libertarian Party. In 2020, the effect is less clear, but Jo Jorgensen, this year's Libertarian nominee, got 1.84 million votes nationally. Did that help decide any states in Joe Biden's favor? And what's the outlook for third parties more generally? To talk about that, I'm joined by Matt Welch. He's editor-at-large for Reason. So, Matt, how would you compare Jo Jorgensen's impact with what we saw from Stein and Johnson in 2016?

MATT WELCH: The biggest impact the third-party voters had in 2020 is perversely not in voting for the third party in 2020. By which I mean, it's what happened to Gary Johnson voters and Jill Stein voters from 2016. What did those people do? Because the total third-party vote back in 2016 was about 7.8 million people. That's a lot. This time it's going to end up at around 2.6, 2.7 million. Those 5 million people went somewhere. And what we have discovered both in looking at pre-election polls and with the usual grain of salt about polls but also in the results everywhere. Like, state after state, Donald Trump got basically the same percentage give or take a few states that he did last time. But he didn't add any of those voters. Those voters went overwhelmingly for Joe Biden. So that's the biggest impact that they had. Jo Jorgensen, who's not a very well-known person at all, a Clemson University psychology lecturer, she did the second-best result in the history of the Libertarian Party, which, granted, they don't have a history of doing exceedingly well. But that's 1.2%, which is bigger than much higher named candidates, including Gary Johnson back in 2012 Gary Johnson had been a successful two-term governor. So that suggests that the people who at this point stay in the Libertarian Party, they might just be kind of Libertarians at this point. There's a, there is a permanent vote that's larger than it used to be in that party right now. The impact on the race is more, however, about where the kind of spike vote in third party interest it was the highest in 20 years in 2016 where those votes went. They did not go for Donald Trump, they did not like Donald Trump.

GOLDSTEIN: So can we make the assumption that the five million or so people of those folks who ended up going for Biden, did they go for Biden for the same reason it seems a lot of folks who were independents did? They were just a little bit sick of the Trump drama, the Trump rhetoric?

WELCH: Yeah, I think that is completely safe to say. I mean, if you think about voted for Gary Johnson-Bill Weld in 2016, there were, by definition, people who didn't want to vote for, for Donald Trump or Hillary Clinton, in this case. Joe Biden, for his margin of victory I mean, think about it. He's going to beat Donald Trump by about 6 million votes. The difference in third party votes is about 5 million votes. I mean, you could it's not the same people and don't make that that mistake but still, you can't help but notice that overlap. So he will depend, his margin of victory depends on voters who were not enthusiastic necessarily about his platform to the extent they knew anything about it at all. It's people who did not like Donald Trump either his policies, you know, if they're libertarian voters, they probably don't like Donald Trump's authoritarian tendencies, his immigration policies, his anti-free trade policies, his big government policies he expanded government faster than Barack Obama did, measured by dollars. So they probably didn't like any of that. But mostly it's they just don't like the chaos, don't like the guy. So that is not a mandate for a Green New Deal necessarily for those people. Maybe Green Party voters who are voting for him want the Green New Deal. But I think it's more an anti-Trump vote and a sign that Trump was able to grow his vote but not grow his percentage just because it was a bigger election. He couldn't convince people outside of the tent to come in for him.

GOLDSTEIN: So Matt, what moves the momentum, what moves the needle forward for whatever non-Republican or Democrat out there when it comes to running for president, let's say the next time around? Is there more of an open field as we see that a lot of folks voted for Joe Biden simply because they didn't really like Donald Trump or thought Biden was likable but we didn't like his policies, whatever it may be? Does it take where we're at right now in 2020, the fact that, frankly, a lot of people 2016 this goes as well people were not that excited about the two major party candidates. Does that move the needle at all toward not getting a third party candidate with Ross Perot-level percentages, but at least something that really has an impact across the country, not just in select states?

WELCH: A lot of it will depend on what kind of implosion happens or does not happen in both parties, right? The Republican Party is going through its last Trumpism spasm, and we'll see how long that lasts. Could be a long time, who knows? The Democratic Party is always willing to have some kind of, you know, moderate versus [Alexandria Ocasio-Cortez] AOC fight, the Bernie Bros versus the moderates. That could happen as well, and that will impact it. The thing to think about it: 2018 midterms, which is the highest turnout midterms in 100 years, was terrible. It was a wipeout for all third parties and independent candidates. They undershot their polling by so much. Why? Because when you when you really think that the opposing team is going to do horrible things or are just horrible people themselves, you vote for the people to vanquish them, regardless of your lack of affection for the people that you were voting for. So how do you break that cycle? This is one reason why I argue that Jo Jorgensen's total this year is damn impressive. One point two percent. OK, it's tiny. But the fact that she's an unknown person outside of the Libertarian Party and not particularly well-known within says that at least there's, there's some vote there. I know for a fact that people like Justin Amash, the congressman from, from Michigan who became the first Libertarian congressman this year when he switched parties. He was thinking about running for president. And part of the reason why he did not this time around was because the field, the backdrop was so bad. So if the backdrop becomes good, if major parties are engaging in some kind of off-putting civil war amongst themselves, then that opens the space for people with much higher name recognition and, and much better kind of political skill, including a Justin Amash character in that case for the Libertarian Party, but other people for the Greens or others, to open the door for something that expands broader. But it's hard. We have a two-party system.

GOLDSTEIN: Matt Welch is editor-at-large of Reason. Matt, appreciate the time.

WELCH: Thank you very much.

See original here:

How Trump Pushed Third-Party Voters To Choose Biden In 2020 - KJZZ

By the Numbers: Local communities were Biden country in Nov. 3 election – Reporter Newspapers

Local communities of Brookhaven, Buckhead, Dunwoody and Sandy Springs were Biden country in the presidential election, joining other metro Atlanta suburbs in flipping Georgia blue for the first time since 1992.

Democrat Joe Biden earned about 61.1% of the total votes in those four communities, while Republican incumbent Donald Trump won only about 37.5%, according to official precinct-by-precinct results mapped and analyzed by the Reporter in the interactive map shown above. (At press time, a recount requested by Trump was pending, but was not expected to significantly change the results following a previous review that combined aspects of an audit and a recount. That previous review did not alter any local results.)

The map shows how strongly precincts in local communities leaned toward either major-party presidential candidate. The darker the blue, the higher the vote for Democrat Joe Biden, and the dark the red, the higher the vote for Republican Donald Trump. Scroll over the map to see the results for individual precincts.

Biden handily won each of the communities as well, with the following approximate percentages:

Brookhaven

Biden 64.5%, Trump 34%

Buckhead

Biden 60.7%, Trump 38.1%

Dunwoody

Biden 59%, Trump 39.6%

Sandy Springs

Biden 60.8%, Trump 37.5%

As the Reporters map shows, Trump lost every precinct in Brookhaven and polled no higher than the 50% range in Dunwoody. (Numbers for Brookhaven are approximate because precinct lines capture some voters outside of the southern city limits.) Sandy Springs had only two precincts that leaned Trump: one in the eastern panhandle above Dunwoody and another in southern High Point around Windsor Parkway.

Buckhead won the distinction of both the bluest and the reddest voting precincts among local communities. Biden took 93.1% of the vote in 06Q, a precinct in the Armour and southern Lindbergh neighborhoods. Trumps best performance 58.2% came in the Kingswood and Randall Mill neighborhoods in western Buckhead.

Trump also prevailed in some precincts in North Buckhead and in neighborhoods along West Paces Ferry Road. Among those was Tuxedo Park, whose residents include Gov. Brian Kemp and U.S. Sen. Kelly Loeffler, the Republican who faces Democrat Rev. Raphael Warnock in one of Georgias two nationally spotlighted runoff elections for U.S. Senate seats coming Jan. 5.

In a handful of local precincts, neither Biden nor Trump won a majority of the votes, including some areas in northern Dunwoody, southern and western Sandy Springs, and Buckheads Paces neighborhood.

Biden and Trump werent the only presidential candidates on the ballot. Libertarian Jo Jorgensen drew small numbers of votes in local precincts. The local Libertarian hotspot? Brookhavens Cross Keys High precinct, where Jorgensen won about 2.5% of the vote.

John Ruch with mapping and analysis by Maggie Lee / maggielee.net

Facebook Twitter LinkedInEmail

See more here:

By the Numbers: Local communities were Biden country in Nov. 3 election - Reporter Newspapers

Charles Koch and Brian Hooks: Believe in People – Reason

Over the past 50-plus years, Charles Koch grew his family business, Koch Industries, into one of the largest privately held companies in America. At the same time, he played a leading role in creating or supporting the modern libertarian movement and some of its major institutions. Among them: The Cato Institute, the Institute for Humane Studies, the Mercatus Center, and the Charles Koch Foundation, a nonprofit that supports many organizations, including Reason Foundation, which is the publisher of Reason magazine. Along with his brother David, a longtime trustee of the Reason Foundation who passed away last year at the age of 79, the 85-year-old billionaire became not only one of the most successful businessmen in the country but also one of the most controversial, with leftists blaming "the Koch brothers" for many of our contemporary problems.

Koch has just published Believe in People, a book that seeks to "offer a paradigm shift [that] calls for all of us to move away from the top-down approach to solving the really big problems" by instead "empowering people from the bottom up to act on their unique gifts and contribute to the lives of others."

In a conversation with Koch and his co-author, Brian Hooks, who is the chairman and CEO of Stand Together and the president of the Charles Koch Foundation, Reason's Nick Gillespie discusses the 2020 election, the successes and failures of the libertarian movement, and what Koch and Hooks see as the defining challenges and opportunities in the coming decade.

For a video version of this interview, go here.

Read more from the original source:

Charles Koch and Brian Hooks: Believe in People - Reason

Pennsylvania certifies Biden as winner of presidential vote – WXII The Triad

Video above: Giuliani argues to block Biden win in PennsylvaniaDemocrat Joe Biden was certified Tuesday as winner of the presidential election in Pennsylvania, culminating three weeks of vote counting and a string of failed legal challenges by President Donald Trump.Democratic Gov. Tom Wolf first disclosed in a tweet that the Department of State had certified the vote count for president and vice president.Wolf sent a certificate of ascertainment to the national archivist Washington with the slate of electors who support President-elect Biden and Vice President-elect Kamala Harris.Pennsylvania's 20 electors, a mix of elected Democrats, party activists and other staunch Biden backers, will meet in the state Capitol on Dec. 14.One of them, state Democratic Party chair Nancy Patton Mills, said she will also lead the Electoral Colleges meeting in Harrisburg next month.Patton Mills said she was gratified that Pennsylvania was the state that made it possible for Biden to win.Bidens win in the state, giving him its haul of 20 electoral votes, put him over the 270 needed and led The Associated Press to declare him the president-elect four days after Election Day. Biden has collected 306 overall electoral votes to Trump's 232.The Pennsylvania results show Biden and Harris with 3.46 million votes, Trump and Vice President Mike Pence with 3.38 million, and Libertarian Jo Jorgensen with 79,000.Democratic Secretary of State Kathy Boockvar, in a news release, called the states election officials and poll workers the true heroes of our democracy.We are tremendously grateful to all 67 counties who have been working extremely long hours to ensure that every qualified voters vote is counted safely and securely, Boockvar said.Trump made Pennsylvania a centerpiece of his unsuccessful legal attempts to invalidate the election results, launching legal attacks on vote counting rules and county election procedures.A federal judge on Saturday dealt a serious blow to the Trump campaigns legal efforts by dismissing a lawsuit that he said lacked evidence and offered strained legal arguments without merit and speculative accusations.The federal government on Monday recognized Biden as the "apparent winner of the national presidential contest.

Video above: Giuliani argues to block Biden win in Pennsylvania

Democrat Joe Biden was certified Tuesday as winner of the presidential election in Pennsylvania, culminating three weeks of vote counting and a string of failed legal challenges by President Donald Trump.

Democratic Gov. Tom Wolf first disclosed in a tweet that the Department of State had certified the vote count for president and vice president.

Wolf sent a certificate of ascertainment to the national archivist Washington with the slate of electors who support President-elect Biden and Vice President-elect Kamala Harris.

Pennsylvania's 20 electors, a mix of elected Democrats, party activists and other staunch Biden backers, will meet in the state Capitol on Dec. 14.

One of them, state Democratic Party chair Nancy Patton Mills, said she will also lead the Electoral Colleges meeting in Harrisburg next month.

Patton Mills said she was gratified that Pennsylvania was the state that made it possible for Biden to win.

Bidens win in the state, giving him its haul of 20 electoral votes, put him over the 270 needed and led The Associated Press to declare him the president-elect four days after Election Day. Biden has collected 306 overall electoral votes to Trump's 232.

The Pennsylvania results show Biden and Harris with 3.46 million votes, Trump and Vice President Mike Pence with 3.38 million, and Libertarian Jo Jorgensen with 79,000.

Democratic Secretary of State Kathy Boockvar, in a news release, called the states election officials and poll workers the true heroes of our democracy.

We are tremendously grateful to all 67 counties who have been working extremely long hours to ensure that every qualified voters vote is counted safely and securely, Boockvar said.

Trump made Pennsylvania a centerpiece of his unsuccessful legal attempts to invalidate the election results, launching legal attacks on vote counting rules and county election procedures.

A federal judge on Saturday dealt a serious blow to the Trump campaigns legal efforts by dismissing a lawsuit that he said lacked evidence and offered strained legal arguments without merit and speculative accusations.

The federal government on Monday recognized Biden as the "apparent winner of the national presidential contest.

Go here to read the rest:

Pennsylvania certifies Biden as winner of presidential vote - WXII The Triad

The Thorough Analysis Of The Global Biochemistry Analysers market Research During COVID-19 Health Crisis – The Courier

A new independent global Biochemistry Analysers Market research report by retailer name is a perfect blend of qualitative and quantitative data to make better informed evaluation to analyze competition. The report covers geographic evaluation that comprises areas such as Europe, North America, South America, Asia-Pacific, and essential vendors/players such as Players With number of figures and tables examining the Biochemistry Analysers market, the study offers you a one-stop, visual breakdown of the leading submarkets, products, and market leaders market revenue prediction as well as evaluation for the years to come.

Check discount and get customization for global Biochemistry Analysers market research report @ https://spiremarketresearch.com/report/covid19-impact-biochemistry-analysers-market-295233#inquiry-for-buying

The objective of the global Biochemistry Analysers market research report is to define market sizes of various countries and segments in recent years and to predict the values to the years to come. The report is developed to incorporate both quantitative and qualitative factors of the market within each of the countries and areas comprised in the global Biochemistry Analysers market research report. In addition to this, the report also caters the detailed data about the essential factors such as challenges and driving factors which will define the future development of the market. Moreover, the global Biochemistry Analysers market research report shall also contain available opportunities in micro markets for stakeholders to invest together with the comprehensive study of product offerings and competitive landscape of major players. The detailed sections and sub-sections of the market are explained in the global Biochemistry Analysers market research report.

The global Biochemistry Analysers market research report includes qualitative commentary and exploratory survey on changing market dynamics with market estimates and sizing for business segments, global countries, and applications. The identification of emerging players is completed by listing some of the major industry players.

Thermo Fisher ScientificAbbottHORIBASiemens HealthcareXylem AnalyticsAgappe DiagnosticsRMSMicroLab InstrumentsLabindia Instruments

The Biochemistry Analysers

Get inside scoop of the global Biochemistry Analysers market research report, request for sample @: https://spiremarketresearch.com/report/covid19-impact-biochemistry-analysers-market-295233#request-sample

Recent analysis shows high development emerging leaders and players by market share that are presently attracting exceptional attention. It also motivates managers and executives to study deeply complementary research metric. The evaluations also provide insight into the size and share of different segments in the global -Biochemistry Analysers market. The scope of the global Biochemistry Analysers market research report includes market break-up or segmentation too.

Early buyers are entitled to get discount on standard edition or customization on reports at no added cost. Get more details @ https://spiremarketresearch.com/report/covid19-impact-biochemistry-analysers-market-295233#inquiry-for-buying

The global Biochemistry Analysers market research report mentions examples of different market business strategies and development activities that industry players are accepting to overcome economic challenges and to match demand supply gap. A detailed main business information, company profile, sales, SWOT analysis, average price, revenue, % market share of select players, and gross margin would be available in the global Biochemistry Analysers market research report.

The study also contains the major strategic developments of the market, including new product launch, R&D, agreements, M&A, partnerships, collaborations, regional growth, and joint ventures of the leading competitors active in the market on a regional and global scale.

Go here to read the rest:
The Thorough Analysis Of The Global Biochemistry Analysers market Research During COVID-19 Health Crisis - The Courier

Difficult Decisions 101: Balancing hands-on learning and safety – University of Michigan News

While new University of Michigan COVID guidelines are requiring most undergraduates to study from their homes for the winter semester, some classesclasses that are nearly impossible to conduct onlinewill continue to be taught in person.

Biochemistry 352 is one such class. Theres something essential about being in a lab to learn this kind of science, says U-M researcher Neil Marsh.

Srijoni Majhi.

Its the difference between driving a car and reading a book about driving a car. We think of lab experience as being mission-critical to teaching the undergraduates, said Marsh, professor of chemistry in the College of Literature, Science, and the Arts and professor of biological chemistry at Michigan Medicine. We did run remote labs but its a very, very poor substitution for a real lab.

Chemistry, he says, more than other types of science, relies on hands-on learning in the lab. Students in his Biochemistry 352 class learn basic biochemical techniques critical to performing experiments in chemistry. Seemingly straightforward skills such as using pipettes can be more complex when students use the instruments in person.

Of course, the ability to teach students these techniques was upended as the university attempted to deal with the coronavirus pandemic. During the fall semester, just 20% of class credit hours were offered in person.

The chemistry department revamped classes to ensure they met safety protocols. Marshs course includes about 100 students and typically involves a lecture and four sections of labs. Now, Marsh records 15-20 minute videos on certain topics that the students then watch before they attend their lab.

Typically, each of the four lab sections would meet once a week, with 16 students and one graduate student instructor leading the section. Now, only six people are allowed in a labfive students and a graduate instructorat a time. For all of the 100 students in the class to attend lab, extra sections had to be added and students attended lab every other week.

Balancing the desire to offer students hands-on experience and the safety of both graduate instructors and students has been a delicate process. The chemistry department offered students and graduate instructors the choice to attend or teach in person. Students uncomfortable with attending class in person could choose classes that were entirely virtual, and their ability to graduate was not compromised if they did not choose to take an otherwise required lab. The department likewise honored graduate instructors wishes to teach in person or virtually.

A survey was given to graduate student instructors to get their preferences as to whether or not they were willing to teach in person, and the only people that saw the results were the departments associate chair and one staff member, said Robert Kennedy, chair of the Department of Chemistry. The bigger point is that nobody was, or will be in winter, assigned to an in-person section if they do not want to teach an in-person section.

If no instructor wants to teach an in-person lab during the winter, Kennedy says, the department will hold no in-person labs.

In September, the Graduate Employees Organization called a strike to address health and safety concerns for GEO members working on campus. The group called for increased COVID testing, among other considerations. The organization ended its strike Sept. 16, accepting a stronger process to address these concerns. Now, for the winter semester, U-M will pare down the number of students on campus, reducing density in undergraduate residence halls and including increases in asymptomatic testing to detect virus infection.

Srijoni Majhi is one of the graduate students who volunteered to teach a lab section during the fall semester. She says she initially felt hesitant because she didnt want to spread the virus to her labmates and roommates.

Its not me alone. I have a roommate, and then I have my other labmates, Majhi said. If Im exposed, then its certain that the other people will be suffering because of me. But I talked to my labmates and they were very supportive.

Ironically, students may be safest in the biochemistry lab, says Marsh. Lab coats, glovesand goggles have long been required wear, and students, as everywhere on campus, are required to wear masks. Graduate student instructors also disinfect the labs after every class.

Theres also very good ventilation in the lab, Marsh said. In some ways, theyre actually much safer doing our lab course than they are pretty much anywhere else on campus, in terms of risk of exposure to the virus.

Its the ability to teach experiments that Majhi found most necessary in having an in-person labespecially this course, which is a new class. Students are familiar with general chemistry, and some students have already worked in research biology or biochemistry labs in other parts of the university. But for other students, this class is their introduction to the subject.

This is a 300-level course, so the students come very prepared to lab, but there are still students who we still have to help, she said. We have to keep in mind this is a very new biochemistry lab, so many of them are not aware of how to use pipettes or work with enzymes, or other simple techniques.

Jack Toor is an undergraduate who opted to take the in-person lab. A biochemistry major, Toor has done research in the U-M School of Dentistry. The first hands-on experience to surprise him? Pipetting.

We did this experiment in the beginning of our lab which seemed on the surface very lame. It was just learning how to use pipettes, said Toor, who plans to apply to medical school. I have been using those in my dental lab for a very long time, but I had never thought about how accurate they are, even after calibration.

The simple experiment involved asking the students to pipette ever-smaller amounts of waterdown to 20 microliters.

Ive never realized, once you get down to such low volumes, it actually is quite inaccurate, he said.

Another experiment the undergraduates performed was to identify proteins based on their molecular weights. The students put proteins in an acrylamide gel and ran an electric current through the gel. This arranges the proteins in proportion to their mass. Toor said to conduct this experiment himself was more valuable than being given the parameters of the experiment in an online format. After all, experiments shown in a video typically dont contain a blooper reel.

When I took my gel out of its casing, it ripped, and thats something your textbook never talks about, Toor said. I talked to Srijoni about it, who told me after I stained it, I would still be able to piece it back together. Its little things like that that your textbook wouldnt mention.

The changes the chemistry department has had to implement to meet safety requirements do have their silver linings, Marsh says. Although students are in the lab less frequently, the time they spend there might be higher quality. The student-to-teacher ratio is lower, and instead of having to share lab equipment to perform experiments with a partner or group, each student has his or her own equipment.

Now theres a much better teacher-to-student ratio in the lab, and students can really get the attention and help they need. Even though theyre only coming in every other week, we now have enough equipment that every student can do the experiment themselves, Marsh said. Weve also really prioritized the fact that were going to use that whole four-hour period. What weve seen is that the students have come to lab very focused. They really get down and do the work.

Originally posted here:
Difficult Decisions 101: Balancing hands-on learning and safety - University of Michigan News

UO’s von Hippel receives Biophysical Society award | Around the O – AroundtheO

UO biophysical chemist Peter von Hippel has been recognized as the 2021 recipient of the Ignacio Tinoco Award from the Biophysical Society for his exceptional contributions to the field of biophysics.

An emeritus professor in the Department of Chemistry and Biochemistry and a member of the Institute of Molecular Biology, von Hippel has spent decades developing approaches to studying the molecular basis of gene expression and played a leading role in creating the major discipline of modern molecular biophysics.

The award really honors all the great people who have worked in my lab over the last 50 years and in many cases have subsequently gone on to having successful scientific careers of their own, von Hippel said.

Named after the late Ignacio Nacho Tinoco, a pioneering biophysicist, educator and mentor at the University of California, Berkeley, the Tinoco Award recognizes investigators in the field of biophysics who have made major scientific contributions, while also maintaining collaborative, inclusive and engaging environments.

Von Hippel has mentored, educated and inspired many students and colleagues over the years, say those who know him, such as Andy Marcus, a professor in the Department of Chemistry and Biochemistry. Marcus has worked with von Hippel in recent years to develop new approaches to studying the mechanisms and dynamics of the central biological processes of DNA transcription and replication.

Its really not possible to overstate the significance of Pete von Hippels scientific impact over the course of his 50-plus-year career, Marcus said. He is an accomplished leader in every sense of the word. In spite of his huge scientific stature, Pete is remarkably modest.To interact with him scientifically is an enriching experience because henaturallyworks to elevate everyone around him.

After finishing his doctorate at Massachusetts Institute of Technology in 1955, von Hippel became a researcher, as well as a commissioned officer in the U.S. Navy, at the Naval Medical Research Institute in Bethesda, Maryland. In 1959 he became an assistant, and then an associate, professor in the Department of Biochemistry at Dartmouth Medical School in Hanover, New Hampshire.

He moved to Oregon in 1967 to continue his National Institutes of Health- and National Science Foundationsupported research and teaching in the fields of biophysical chemistry and molecular biology. He was honored by election to the National Academy of Sciences in 1978, to the American Academy of Arts and Sciences in 1979 and to the American Philosophical Society in 2004. He was also appointed a Career American Cancer Society Research Professor in 1989.

Von Hippel uses physical biochemical approaches to study the molecular basis of gene expression. As Marcus describes it, von Hippel is largely responsible for writing the modern "rule book to understand the physical-chemical basis of how genetic macromolecules, like DNA and RNA, carry out their biological functions and is recognized by biochemists and biophysicists around the world for his pioneering work.

Bruce Blonigen, dean of the College of Arts and Sciences, pointed to the significant impact of von Hippels hundreds of published research papers and the numerous high-level research grants he has received over the years.

Even more extraordinary is the significance of the discoveries he has made and how it has advanced our knowledge of the molecular basis of gene expression, Blonigen said. Im thrilled that his career achievements have been recognized by this award.

Excerpt from:
UO's von Hippel receives Biophysical Society award | Around the O - AroundtheO

The Biochemistry Analyser Market To Revive The Growth Indices, Reach US$ 4700 Million – Cheshire Media

Market Report Summary

For Full Information -> Click Here

Read Full Press Release Below

The clinical use of biochemistry analyzers in measurement solutions such as latex agglutination, ion-selective potentiometry, and colorimetric & photometric testing. In addition to this, accuracy of biochemistry analyzers in analyzing blood and urine samples has benefited pathology labs and diagnostic centers across the globe. Persistence Market Research predicts that the global demand for biochemistry analyzers will continue to soar on the grounds of such factors.

A recent report published by Persistence Market Research projects that by the end of 2024, the global market for biochemistry analyzers will reach US$ 4,625.3 Mn in terms of value.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/6451

Company Profiles

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/6451

Key findings in the report cite that the use of chemistry analyzers spans from high-throughput clinical labs to point-of-care clinics, and its use for testing enzymes, electrolytes and proteins is gaining traction.

The report current values the globalbiochemistry analyzer marketat a little over US$ 3,000 Mn. During the forecast period, revenues generated through global sales of biochemistry analyzers are, thus, expected to soar at a steady CAGR of 5.5%.

Key Research Insights from the Report include:

The global market for biochemistry analyzers represents absolute $ opportunity of US$ 154.6 Mn in 2017 over 2016 and incremental opportunity of US$ 1,570.8 Mn between 2016 and 2024

Apart from clinical diagnostics, critical applications of biochemistry analyzers include drugs-of-abuse testing and diagnostic testing of patients metabolic functions

Access Full Report @ https://www.persistencemarketresearch.com/checkout/6451

Over 40% of biochemistry analyzers sold across the globe during the forecast period will be concentrated in North America

Demand for biochemistry analyzers is also expected to surge in Asia-Pacific, revenues from which will record steadfast growth at 6.1% CAGR

Leading manufacturers of biochemistry analyzers are developing multiplexing analyzers a cost-effective upgrade to existing product line

The report further reveals that fully-automated biochemistry analyzers will remain in great demand in the years to come. In 2017 and beyond, more than 85% of global biochemistry analyzer revenues will be accounted by sales of fully-automated biochemistry analyzers.

Moreover, clinical diagnostics will also remain the largest application of biochemistry analyzers throughout the forecast period. Revenues accounted by global sales of biochemistry analyzers in clinical diagnostics are anticipated to register speedy growth at 5.7% CAGR.

The report further identifies diagnostic centers as largest end-users of biochemistry analyzers in the world. On the other hand, rising number of point-of-care diagnostic labs instated in hospitals will render a key end-user of biochemistry analyzers. Together, hospitals and diagnostics centers will be responsible for procure over two-third of global biochemistry analyzers revenues through 2024.

Explore Extensive Coverage of PMR`sLife Sciences & Transformational HealthLandscape

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMRs collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Ashish KoltePersistence Market ResearchAddress 305 Broadway, 7th FloorNew York City,NY 10007 United StatesU.S. Ph. +1-646-568-7751USA-Canada Toll-free +1 800-961-0353Sales[emailprotected]Website https://www.persistencemarketresearch.com

Go here to see the original:
The Biochemistry Analyser Market To Revive The Growth Indices, Reach US$ 4700 Million - Cheshire Media

McMaster makeup artist wants you to feel beautiful The Silhouette – The Silhouette

Fourth-year student Abi Oladesu is beautifying clients through her business Desu Beauty

Abi Oladesu has been doing makeup for most of her life. She started having fun with her mothers makeup from the age of 10 and decided a few years later to challenge herself to increase her skills. She did someone elses makeup for the first time when she was about 16.

During her second year at McMaster University, the biochemistry student started thinking about taking makeup more seriously. However, it wasnt until she was quarantining during the COVID-19 pandemic that she decided to take the leap and start her business, Desu Beauty on Oct. 30, 2020.

There are three components to Oladesus business. As she has received many requests for makeup tutorials and enjoys teaching, she decided that she would post makeup tutorials on Instagram and offer beginner and intermediate lessons.

The second part of her business involves posting her own makeup looks in order to improve her skills and show clients what she can do. Lastly, she does makeup for clients weddings, photoshoots, proms, graduations and other events.

It is important to Oladesu that when she does clients makeup, she isnt turning them into a different person but highlighting the best parts of them. This goal stems in part from her own experience with makeup. When Oladesu was a preteen and early teenager, she used makeup as a way of hiding her face. Now she uses makeup to accentuate her features and seeks to do the same for her clients.

Obviously nobody wants that for themselves, but I dont think theres anything necessarily bad about [being self-conscious] in the sense that we all feel self-conscious once in a while. Were in a society where the beauty standards are very high and they change all the time, but its important to remember . . . youre the one that at the end of the day determines your worth to other people, said Oladesu.

Were in a society where the beauty standards are very high and they change all the time, but its important to remember . . . youre the one that at the end of the day determines your worth to other people, said Oladesu.

This mission is embedded in the name of Oladesus business. While she originally called it Desu Beauty as a reference to the last four letters of her last name, she realized upon reflection that it had a deeper meaning for her.

Im a very large fan of anime and so desu . . . basically means to be . . . I am [also] Christian [and] in the Bible, its like we are beautifully and wonderfully made . . . So to be that beautifully and wonderfully creative person, you have to love yourself in every aspect, whether thats with wearing your natural face out and being super proud of it or getting the skills to do your makeup really well so that every time you look in the mirror . . . youre like, wow, I feel beautiful, I know Im beautiful. . . . I want you to be the best version of yourself or at least to look at yourself and be like wow, I feel like that beautifully and wonderfully made person, explained Oladesu.

Since she started, Oladesu has received positive reception and a lot of support from family and friends. Unfortunately, the ongoing pandemic has decreased the number of events for which people would get their makeup done. At the same time, Oladesu credits the pandemic with giving her the time to start her business.

Oladesu also sees online classes as a blessing for her since she started her business. Instead of spending all day on campus and then doing makeup appointments, she can better make her own schedule by doing makeup during the day and watching recorded lectures afterwards. Managing the business alongside her demanding degree and other commitments has also encouraged her to better prioritize her time.

Oladesu looks forward to continuing to grow her following and reach more people through her business. As she will be graduating soon, she is considering how she might integrate her love of makeup into her career.

Im definitely a cautious person so . . . right now, I definitely am going to finish my biochemistry degree and Im going to see if I could get a job with that. But working with makeup has gotten me interested in cosmetics in general so [maybe] I can mix my biochemistry major with cosmetics and then possibly go into formulation or something along those lines, said Oladesu.

I definitely am going to finish my biochemistry degree and Im going to see if I could get a job with that. But working with makeup has gotten me interested in cosmetics in general.

To other students with a skill they are considering turning into a business, Oladesu says to just start. She recalls that she felt the need to have high-quality foundations in every colour before she began her business. However, since she started, all her clients have used colours that she had already had.

Theres nothing wrong with humble beginnings. You dont have to have everything, you dont have to have the best of everything, Oladesu said. Its better to just start because honestly, I feel like people appreciate watching you grow and watching you improve.

See the article here:
McMaster makeup artist wants you to feel beautiful The Silhouette - The Silhouette

Biochemistry Analyzer Market 2020 Global Industry Analysis, Trends and Forecast 2026 : Mevion, ProNova, ProTom International, IBA, Varian…

This extensive research report focusing on global Biochemistry Analyzer market portrays a detailed analytical assessment of notable trends, future specific market growth opportunities, end-user profile as well as challenge overview of the current Biochemistry Analyzer market scenario has also been encapsulated in the report. The primary focus of the report is to highlight and understand multiple market developments across the global Biochemistry Analyzer market ecosystem that influence logical reader discretion.This ready-to-refer market intelligence report on global Biochemistry Analyzer market entails a detailed analysis of the industrial ecosystem, followed by a highly reliable segment overview evaluated on multi-factor analysis, market size and dimensions in terms of volumetric gains and returns.

Get sample copy of Biochemistry Analyzer Market report @ https://www.orbispharmareports.com/sample-request/79842

Competitive Landscape Detailed Analysis:

* Followed by constant and thorough research initiatives in data unraveling process pertaining to global Biochemistry Analyzer market, stringent curation processes have been directed to understand growth prognosis and development spanning across regional hubs and their respective performance and evaluation in terms of various macro and micro elements that decide further growth prognosis in global Biochemistry Analyzer market.* The competitive analysis section of this report on global Biochemistry Analyzer market is dedicated to identifying and profiling various players in terms of their market positioning, product and service developments, technological investments as well as milestones achievement.* The report is aimed to enable seamless understanding and comprehension of the multi-faceted developments. Further in the report, readers are also offered substantial cues and hints on market strategies undertaken by various manufacturers operating across local and global realms.* An effortless deduction of the strategies aid market players to know the potential of these business tactics and tricks and their potential in steering high revenue growth and concomitant returns in global Biochemistry Analyzer market.Besides presenting a detailed synopsis of the current market scenario, this section of the report also includes versatile details on the overall ecosystem, key trends, market catalysts as well as threats and challenges that seem to significantly impact revenue generation in the Biochemistry Analyzer market.

Major Company Profiles operating in the Biochemistry Analyzer Market:

QIAGENAbbottBio-Rad LaboratoriesEMD Millipore CorporationSigma-AldrichAgilent TechnologiesGE HealthcareBeckman Coulter/DanaherTakara BioRocheThermo Fisher ScientificBD

Browse the complete report @ https://www.orbispharmareports.com/global-biochemistry-analyzer-market-report-2019-competitive-landscape-trends-and-opportunities/

Frequently Asked Questions:

* In terms of product and application based segmentation, which segment is likely to remain most promising?* Based on concurrent developments, which trends are likely to remain most dominant through the forecast span?* Considering the pandemic crisis and other associated alterations, what could be the most relevant market projections?* Who would continue to remain atop the growth curve in global Biochemistry Analyzer market through the forecast years?* What are the top threats and challenges identified in the Biochemistry Analyzer market?

By the product type, the market is primarily split into

Type 1Type 2Type 3

By the application, this report covers the following segments

ResearchMolecular BiotechnologyHuman ImmunologyGeneticsDiagnosisBiosciencesEducation

The report representing the global Biochemistry Analyzer market is an intensive research based documentation shedding enormous light on market developments, noteworthy trends as well a competitive vendor activities and performance analysis besides evaluating competition positioning that gradually direct hefty revenue flow and sustenance in global Biochemistry Analyzer market. The report also entails significant details on COVID-19 spread and their effective management.Further in the report reading, readers are expected to win cues on exclusive regional and country specific elements of the Biochemistry Analyzer market. Besides segregating the growth hotspots, this section embodies versatile understanding concerning various growth harnessing industrial practices as well as strategic aid favoring uncompromised growth and sustainable revenue returns in global Biochemistry Analyzer market.

For Any Query on the Biochemistry Analyzer Market: https://www.orbispharmareports.com/enquiry-before-buying/79842

About Us :

At Orbispharma we curate the most relevant news stories, features, analysis and research reports on the important challenges undertaken by the pharmaceutical and related sectors. Our editorial philosophy is to bring you sharp, focused and informed perspective of industries, the end users and application of all upcoming trends into the pharma sector. Orbispharma believes in conversations that can bring a change in one of the most crucial economic sectors in the world. With these conversations we wish our customers to make sound business decisions with right business intelligence.

Contact Us :

Read the original here:
Biochemistry Analyzer Market 2020 Global Industry Analysis, Trends and Forecast 2026 : Mevion, ProNova, ProTom International, IBA, Varian...

ICMR NIIH Recruitment 2020 for Lab Technician and other Posts @main.icmr.nic.in, Check Eligibility/Application Process Here – Jagran Josh

ICMR National Institute of Immunohaematology (ICMR - NIIH), Department of Health Research, Ministry of Health and Family Welfare, Government of India has invited applications for the Lab Technician, Senior Research Fellow posts on its official website.

ICMR NIIH Recruitment for Lab Technician

ICMR National Institute of Immunohaematology (ICMR - NIIH)Jobs Notification: ICMR National Institute of Immunohaematology (ICMR - NIIH), Department of Health Research, Ministry of Health and Family Welfare, Government of India has invited applications for the Lab Technician, Senior Research Fellow posts. Interested and eligible candidates can apply for ICMR NIIH Recruitment 2020 on or before to 03 December 2020.

Candidates having certain educational qualification including M.Sc. in Life Science/Microbiology/Genetics/Molecular Biotechnology/Biochemistry and 10 + 2 in Sciences can apply for ICMR NIIH Recruitment 2020.

Candidates willing to apply for ICMR NIIH Recruitment 2020 can go through this article for application process, age limit, post wise qualification, experience, selection criteria, how to apply etc here.

Notification details for ICMR NIIH Recruitment 2020:Ref No: ICMR/NIIH/ Advt.1/20-21Date: 23 November 2020

Important Dates for ICMR NIIH Recruitment 2020:Last Date for Submission of Application: 03 December 2020

Vacancy Details for ICMR NIIH Recruitment 2020:Senior Research Fellow-04Lab Technician-01

Eligibility Criteria for ICMR NIIH Recruitment 2020:Educational QualificationSenior Research Fellow-Candidates should have M.Sc. in Life Science/Microbiology/Genetics/Molecular Biotechnology/ Biochemistry with 2 years research experience.Desirable: Experience in Molecular Biology.Lab Technician- 10+ 2 in Science subjects and two years Diploma in Medical LaboratoryTechnology (DMLT)Desirable: B.Sc. Life Science /Microbiology/Biochemistry/Biotechnology.Candidates should check the notification link for details of the Educational Qualification of the Posts.

Age Limit (As on 01 December 2020) for ICMR NIIH Recruitment 2020:Senior Research Fellow-28 yearsLab Technician- 30 yearsAge relaxation for SC/OBC/PWD and Experience candidate will be as per the rules.

ICMR NIIH Recruitment 2020: PDF

How to Apply for ICMR NIIH Recruitment 2020:Interested and eligible candidates can download the application from the official website -http://www.niih.org.in and fill it with his/her own handwriting and send the same to the mail id- estniih1310@gmail.com on or before 03 December 2020. Please check the short notification for details in this regard.

Link:
ICMR NIIH Recruitment 2020 for Lab Technician and other Posts @main.icmr.nic.in, Check Eligibility/Application Process Here - Jagran Josh

November 2020: Kaplan MCAT stumpers put premeds to the test – American Medical Association

If youre preparing for theMedical College Admission Test(MCAT),you are going to want to consult the experts. These selections from Kaplans MCATQuestion of the Day seriescan help you sharpen your skills as you prepare to begin your potential journey into medical training.

The questions below come from three of the four MCAT sectionsbiological and biochemical foundations of living systems; chemical and physical foundations of biological systems; and psychological, social, and biological foundations of behavior. A fourth section, critical analysis and reasoning skills (commonly referred to as CARS), is based largely on inference.

Medicine can be a career that is both challenging and highly rewarding but figuring out a medical schools prerequisites and navigating the application process can be a challenge unto itself. For studentspreparing for the medical school, theAMA premed glossary guidehas the answers to frequently asked questions,

For those already in medical school, the AMA selected Kaplan as apreferred providerto support you in reaching your goal of passing the USMLEor COMLEX-USA.AMA members can save 30% on access to additional study resources, such as KaplansQbankand High-yield courses.

Section: Biological and biochemical foundations of living systems

Question: Which of the following characteristics is NOT attributed to antibodies?

A. Antibodies bind to more than one distinct antigen.

B. Antibodies label antigens for targeting by other immune cells.

C. Antibodies can cause agglutination by interaction with antigen.

D. Antibodies have two heavy chains and two light chains.

The correct answer is A.

Kaplan explains why: Antibodies are specific to a single antigen. Each B-cell produces a single type of antibody with a constant region that is specific to the host and a variable region that is specific to an antigen.

Section: Chemical and physical foundations of biological systems

Question: Photons and other energy sources can excite electrons into higher energy levels, though these excitations are typically short-lived. X-ray imaging succeeds because different tissue types are differently able to absorb the energy of a photon in order to excite an electron. Suppose an electron falls from n = 4 to its ground state, n = 1. Which of the following effects is most likely?

A. A photon is absorbed.

B. A photon is emitted.

C. The electron moves into a p-orbital.

D. The electron moves into a d-orbital.

The correct answer is B.

Kaplan explains why: Because the electron is moving into the n = 1 shell, the only subshell available is the 1s subshell, which eliminates choices (C) and (D). There will be some energy change, however, as the electron must lose energy to return to the minimum-energy ground state. That will require emitting radiation in the form of a photon.

Section: Psychological, social, and biological foundations of behavior

Question: A stroke patient comprehends speech but cannot move her mouth to form words. Which of the following brain areas is likely affected?

A. Brocas area

B. Wernickes Area

C. Arcuate fasciculus

D. Superior temporal gyrus

The correct answer is A.

Kaplan explains why: Brocas area governs the motor function of language. A stroke that affects Brocas area will leave receptive language intact, but word formation will be affected. A stroke affecting Wernickes area, choice (B), will make it so the individual is unable to comprehend speech. A stroke affecting the arcuate fasciculus, choice (C), will result in an inability to repeat words heard but spontaneous language production is intact. The superior temporal gyrus, choice (D), is where Wernickes area is located.

Continue reading here:
November 2020: Kaplan MCAT stumpers put premeds to the test - American Medical Association